binding and signaling. This is an interesting finding be- D-20246 Hamburg, Germany. cause glucocorticoids have been shown to suppress AP-
A new partnership between TGF-␤1 and glucocorticoids in the network of inflammation
The past decades have seen the discovery of a myriad of coids have been shown to down-regulate activity of nupro-and anti-inflammatory molecules. Interleukins (IL), clear factor-kappa B (NF-B) in various models of chemokines, glucocorticoids, and the transforming growth glomerulonephritis. They ameliorate local inflammation factor beta (TGF-␤) superfamily, to name a few, all particand facilitate apoptosis in mesangial cells. The numerous ipate in the process of inflammation. Moreover, it has effects of glucocorticoids are mediated through interaction become quite obvious that the behavior of these molecules of their corresponding glucocorticoid receptors with the tends to act beyond cliches of black and white. Many nucleus. of the so-called proinflammatory mediators exert under Glucocorticoids and the TGF-␤ family interact in many certain circumstances anti-inflammatory effects or play a different ways. In human T lymphocytes glucocorticoids role in the resolution of inflammation and vice versa. Thus, increase the expression of TGF-␤1 by up-regulation of regulation of the homeostasis of inflammation is complex transcription [3] . In human osteoblast-like cells, steroids and depends on a wide range of regulatory loops. A large augment the levels of functional TGF-␤ by facilitating the array of molecules regulate each other, and the effect on cleavage of the latency associated peptide [4] . In another the inflammatory process varies, depending on the model system, however, glucocorticoids down-regulate TGF-␤1 and the time course of inflammation. and 2 expression in lung fibroblasts, by the interception In this issue of Kidney International, Baud et al [1] of an intrinsic positive feedback control mechanism for describe a new and intriguing mechanism of interaction TGF-␤ [5] . A synergy of glucocorticoids and TGF-␤1 exbetween TGF-␤1 and glucocorticoids in a model of human ists, however, in fibrotic tissue remodeling [6] . These exmacrophages. Their data add to the complexity of the amples emphasize the complexity and the importance of process of inflammation and its resolution, but also make interactions between glucocorticoids and TGF-␤ in differit more interesting. ent cell types and even in more complex pathophysiologic Since its discovery approximately 20 years ago, the situations. TGF-␤ family of polypeptides has undergone extensive Baud et al [1] demonstrate in this issue of Kidney Interstudies. To date, five different members are identified national a new direct effect of TGF-␤1 on glucocorticoid in vertebrates. Three members (TGF-␤1, 2, and 3) are binding and signaling in human U 937 cells. They show expressed in mammals. TGF-␤ inhibits growth of many very convincingly that the exposure of U 937 cells to hematopoetic and epithelial cells and plays a major role TGF-␤1 increases dexamethasone specific binding, which in the production of extracellular matrix. TGF-␤s exert is due to an increase of binding sites. The signal transducpivotal effects on developmental processes, cell cycle regution cascade of the TGF-␤ superfamily has the shape of lation, and acute and chronic inflammation. Increased an hour glass. Signaling is mediated through a tetrameric TGF-␤ formation has been reported and linked to the receptor complex, consisting of two heterodimers of one production of extracellular matrix in a large number of of seven different type I and one of five type II transmemdifferent animal models and human renal diseases. Varibrane proteins. Receptor Smad proteins (Smad1 to Smad3, ous stimuli such as angiotensin II, thromboxane A 2 , reacSmad5, and Smad8) are then activated via phosphorylative oxygen species and high glucose are known to regulate tion by the type I receptor subunit and accumulate in collagen formation in renal tissue due to effects on TGF-␤.
the nucleus after association with the Co-Smad protein Therefore, TGF-␤ is a central player in initiation and (Smad4). Here this heteromeric complex can interact resolution of renal inflammation [2] . Another family of with a wide range of DNA-binding proteins, such as hormones with an even wider range of effects are the activator protein-1 (AP-1), stimulatory protein-1 (SP-1) glucocorticoids. One very well-known and therapeutically and many others, to regulate transcription of a multitude widely used effect of glucocorticoids is the control of tranof genes. A great number of interactions between the scription of pro-and anti-inflammatory genes. Glucocorti-TGF-␤ pathway and that of other signal cascades as well as Smad-independent pathways have been reported [7] . Baud et al [1] now demonstrate that both Smad2 and
